Elon Boms’ Post

This article by the WSJ is critically important for public health officials and HealthTech entrepreneurs to internalize. We need multiple solutions for patients to move towards post GLP-1 usage. These solutions need to be easy to implement, non-disruptive to daily life and focused on caloric restriction , lifestyle change and muscle gain. Too many startups are still focused on GLP-1 prescription and delivery. Not enough people focused on the next stage of the weight management journey. As the Journal states, the benefits of the GLP-1 craze are only going to be successful long term if the transition off of them is successful. Otherwise, we risk unforeseen, long term consequences to a large group of patients stuck on GLP-1's with no healthy way to transition off. https://lnkd.in/dYBd3HaN Meghan FitzGerald James Stearns Dominic Perks John LaMattina Raju Kucherlapati

The Quest for Treatments to Keep Weight Off After Ozempic

The Quest for Treatments to Keep Weight Off After Ozempic

wsj.com

Meghan FitzGerald

Investor|Professor|BoardMember

6mo

GLP/GIP step down therapy will be its own market segment.... stepping back into muscle strength, energy and eating healthy.

To view or add a comment, sign in

Explore topics